OCT 03, 2016 02:38 PM PDT

Investigation Finds 80% of Chinese Clinical Trial Data are Fraud

A quality control survey of clinical trials in China has revealed gross misconduct in how the data for these trials were handled. The investigation alleges that more than 80 percent of data in these clinical trials were manipulated, doctored, and outright fabricated.

Chinese clinical trials lose credibility | Image: pixabay.com

Led by the Chinese State Food and Drug Administration (SFDA), the investigation reviewed data from over 1,600 clinical trials. These involved trials set to receive regulator approval for mass production. The expose was covered by the Economic Information Daily newspaper.

In the expose, SFDA found that more than 80 percent of the data showed scientific dishonesty and corruption at nearly every level. This included deletion of records for adverse events associated with treatments, and massaging data into desired outcomes.

More egregiously, the investigation found that the results of some clinical trials were concocted even before the study began.

This is a "breach of duty by supervision departments and malpractice by pharmaceutical companies, intermediary agents and medical staff," the State Food and Drug Administration (SFDA) said in its report, highlighting deliberate deceit at all levels. Even third party agencies such as contract research organizations whose jobs are to manage and inspect clinical trial facilities were found to be fraudulent and cited as “accomplices in data fabrication due to cutthroat competition and economic motivation.”

Clinical data fabrication is apparently a systemic problem that’s “an open secret even before the inspection,” said an unnamed source in the newspaper.

The problem may boil down to competition. And in a market where every pharmaceutical company is trying to earn approval to mass market a Western drug for profit, competition seems to have sabotaged scientific and ethical integrity.

"The domestic market for Western pharmaceuticals in China is either confined to very straightforward generic products that have been around for a long time ... or revolves around joint-venture pharmaceutical manufacture with foreign companies," said Luo Liang, a healthcare professional to Radio Free Asia.

"Either that, or Chinese pharmaceutical factories get hold of the formula for certain drugs whose patents have expired," said Luo Liang. "There are no new drugs in development in the same way that there are overseas."

To Liang and others, the degree of fraud in the Chinese clinical trials is wholly unsurprising and could potentially point to other aspects of Chinese science. "It's not just the medicines," said Mai Ke, a rights activist in Guangdon. "In China, everything is fake, and if there's a profit in pharmaceuticals, then someone's going to fake them too."

But perhaps international scrutiny of this problem will prompt swift reforms in how clinical trials will be conducted and inspected in the future in China.
Additional sources: Radio Free Asia, Science Alert
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
MAY 31, 2018
MAY 31, 2018
PUREGRIP: Safe, User-Friendly Bottles for Biomedical Research
Foxx Life Sciences and Borosil Glass Works Joined up to Create a Lab Bottle Breakthrough...
JUN 18, 2018
JUN 18, 2018
Detecting and Diagnosing Rheumatoid Arthritis Before it Begins
Unique gene signatures and tiny changes in the immune system that occur in the earliest stages of rheumatoid arthritis, an autoimmune disease, could soon b...
JUL 11, 2018
Clinical & Molecular DX
JUL 11, 2018
Certain tests better flag fetuses with brain disorder risk
Fetuses with a specific, rare chromosomal aberration have a 20 percent risk of developmental or other brain disorder, new research shows. The work could le...
JUL 11, 2018
Clinical & Molecular DX
JUL 11, 2018
Faster, cheaper TB test makes diagnosis easier in rural areas
  Scientists, working with doctors and public health researchers in South Africa, have created a new tuberculosis test that makes it easier to diagnos...
SEP 15, 2018
Genetics & Genomics
SEP 15, 2018
Data-based Health Management Tool for Aortic Aneurysm
This tool might be extrapolated for many other disorders, and may free patients from repeated doctor visits....
DEC 05, 2018
DEC 05, 2018
Male Contraceptive Gel is in Clinical Trials
Researchers have started a clinical trial involving 420 participants to test the efficacy of a male contraceptive gel....
Loading Comments...